Laboratory chemistry system software defect impairs quality control reporting
A software defect in VITROS XT 3400 Chemistry Systems prevents quality control rules from properly reporting failures in test controls. This may result in erroneous patient test results being reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II device recall with no reported hospitalizations, illnesses, injuries, or deaths. The software defect presents a risk-of-harm situation where patient result errors could occur if quality control checks fail to function properly, fitting the criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Ortho-Clinical Diagnostics is recalling VITROS XT 3400 Chemistry Systems with software versions 3.8.0 or 3.8.1. Affected systems include 25 units in the US and 26 units internationally across multiple countries. These systems are used in clinical laboratories to conduct automated blood chemistry testing.
The affected systems contain a software defect in the configurable Westgard Rules quality control feature. When a new control is defined, the Westgard rules do not flag or report failures when they should occur. This means quality control results that fail acceptance criteria may be incorrectly accepted and not flagged for operator review.
As a result, erroneous patient test results may be reported from the system without being caught by quality control checks. This could affect the accuracy of patient laboratory results and clinical decision-making. Any facility operating an affected VITROS XT 3400 Chemistry System should verify their system software version and serial number against the recall notice.
Affected facilities should contact Ortho-Clinical Diagnostics for instructions on obtaining and implementing the corrective software update to resolve the quality control reporting defect.
The recalled product
- Product
- VITROS XT 3400 Chemistry System, Catalog No. 6844458
- Manufacturer
- Ortho-Clinical Diagnostics, Inc.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Ortho-Clinical Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Ortho-Clinical Diagnostics, Inc.
See all →- ModerateLactate test slides recalled over calibration failures delaying patient results
FDA (Devices) · 2025-09-24
- ModerateLactate slides in 18-slide cartridges recalled over calibration failures delaying results
FDA (Devices) · 2025-09-24
- ModerateCalcium test slides recalled after calibration failures delayed patient results
FDA (Devices) · 2025-08-27
- HighVITROS Performance Verifier I lots can cause quality control drift
FDA (Devices) · 2025-07-23
- HighVITROS CHE slides sold in Japan can cause quality control drift
FDA (Devices) · 2025-07-23
Same hazard · software defect
See all →- HighBaxter Novum IQ Syringe Pump Recalled for Software Infusion Issue
FDA (Devices) · 2026-09-09
- HighBaxter Novum IQ Syringe Pump Software Issue Recall
FDA (Devices) · 2026-09-09
- HighMedos Velys Robotic-Assist Station Recalled for Software Movement Issue
FDA (Devices) · 2026-09-09
- HighMidmark IQecg Digital ECG Software Recall for Inaccurate Waveforms
FDA (Devices) · 2026-09-02
- HighMidmark Digital ECG Software Recall for Incorrect Waveform Display
FDA (Devices) · 2026-09-02